Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 22425995)

1.

Wild-type microglia arrest pathology in a mouse model of Rett syndrome.

Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, Guyenet PG, Kipnis J.

Nature. 2012 Mar 18;484(7392):105-9. doi: 10.1038/nature10907.

2.

The role of microglia in brain maintenance: implications for Rett syndrome.

Derecki NC, Cronk JC, Kipnis J.

Trends Immunol. 2013 Mar;34(3):144-50. doi: 10.1016/j.it.2012.10.002. Epub 2012 Oct 31. Review.

3.

Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate.

Maezawa I, Jin LW.

J Neurosci. 2010 Apr 14;30(15):5346-56. doi: 10.1523/JNEUROSCI.5966-09.2010.

4.

Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli.

Cronk JC, Derecki NC, Ji E, Xu Y, Lampano AE, Smirnov I, Baker W, Norris GT, Marin I, Coddington N, Wolf Y, Turner SD, Aderem A, Klibanov AL, Harris TH, Jung S, Litvak V, Kipnis J.

Immunity. 2015 Apr 21;42(4):679-91. doi: 10.1016/j.immuni.2015.03.013.

PMID:
25902482
5.

Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.

Jentarra GM, Olfers SL, Rice SG, Srivastava N, Homanics GE, Blue M, Naidu S, Narayanan V.

BMC Neurosci. 2010 Feb 17;11:19. doi: 10.1186/1471-2202-11-19.

6.

Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.

Kondo M, Gray LJ, Pelka GJ, Christodoulou J, Tam PP, Hannan AJ.

Eur J Neurosci. 2008 Jun;27(12):3342-50. doi: 10.1111/j.1460-9568.2008.06305.x. Epub 2008 Jun 14.

PMID:
18557922
7.

Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome.

McCauley MD, Wang T, Mike E, Herrera J, Beavers DL, Huang TW, Ward CS, Skinner S, Percy AK, Glaze DG, Wehrens XH, Neul JL.

Sci Transl Med. 2011 Dec 14;3(113):113ra125. doi: 10.1126/scitranslmed.3002982.

8.

Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.

Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY.

Nature. 2010 Nov 11;468(7321):263-9. doi: 10.1038/nature09582.

9.

7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome.

Johnson RA, Lam M, Punzo AM, Li H, Lin BR, Ye K, Mitchell GS, Chang Q.

J Appl Physiol (1985). 2012 Mar;112(5):704-10. doi: 10.1152/japplphysiol.01361.2011. Epub 2011 Dec 22.

10.

Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology.

Nguyen MV, Felice CA, Du F, Covey MV, Robinson JK, Mandel G, Ballas N.

J Neurosci. 2013 Nov 27;33(48):18764-74. doi: 10.1523/JNEUROSCI.2657-13.2013.

11.

Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.

Viola A, Saywell V, Villard L, Cozzone PJ, Lutz NW.

PLoS One. 2007 Jan 17;2(1):e157.

12.

Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.

Robinson L, Guy J, McKay L, Brockett E, Spike RC, Selfridge J, De Sousa D, Merusi C, Riedel G, Bird A, Cobb SR.

Brain. 2012 Sep;135(Pt 9):2699-710. doi: 10.1093/brain/aws096. Epub 2012 Apr 23.

13.

MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits.

Schaevitz LR, Gómez NB, Zhen DP, Berger-Sweeney JE.

Genes Brain Behav. 2013 Oct;12(7):732-40. doi: 10.1111/gbb.12070. Epub 2013 Aug 26.

PMID:
24283265
14.

Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome.

O'Connor RD, Zayzafoon M, Farach-Carson MC, Schanen NC.

Bone. 2009 Aug;45(2):346-56. doi: 10.1016/j.bone.2009.04.251. Epub 2009 May 3.

15.

A role for glia in the progression of Rett's syndrome.

Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK, Hirrlinger PG, Kirchhoff F, Bissonnette JM, Ballas N, Mandel G.

Nature. 2011 Jun 29;475(7357):497-500. doi: 10.1038/nature10214.

16.

Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome.

Castro J, Garcia RI, Kwok S, Banerjee A, Petravicz J, Woodson J, Mellios N, Tropea D, Sur M.

Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9941-6. doi: 10.1073/pnas.1311685111. Epub 2014 Jun 23.

17.

A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome.

Samaco RC, Fryer JD, Ren J, Fyffe S, Chao HT, Sun Y, Greer JJ, Zoghbi HY, Neul JL.

Hum Mol Genet. 2008 Jun 15;17(12):1718-27. doi: 10.1093/hmg/ddn062. Epub 2008 Mar 4.

18.

Wild-type microglia do not reverse pathology in mouse models of Rett syndrome.

Wang J, Wegener JE, Huang TW, Sripathy S, De Jesus-Cortes H, Xu P, Tran S, Knobbe W, Leko V, Britt J, Starwalt R, McDaniel L, Ward CS, Parra D, Newcomb B, Lao U, Nourigat C, Flowers DA, Cullen S, Jorstad NL, Yang Y, Glaskova L, Vigneau S, Kozlitina J, Yetman MJ, Jankowsky JL, Reichardt SD, Reichardt HM, Gärtner J, Bartolomei MS, Fang M, Loeb K, Keene CD, Bernstein I, Goodell M, Brat DJ, Huppke P, Neul JL, Bedalov A, Pieper AA.

Nature. 2015 May 21;521(7552):E1-4. doi: 10.1038/nature14444. No abstract available.

PMID:
25993969
19.

Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity.

Jin LW, Horiuchi M, Wulff H, Liu XB, Cortopassi GA, Erickson JD, Maezawa I.

J Neurosci. 2015 Feb 11;35(6):2516-29. doi: 10.1523/JNEUROSCI.2778-14.2015.

PMID:
25673846
20.

Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.

Itoh M, Ide S, Takashima S, Kudo S, Nomura Y, Segawa M, Kubota T, Mori H, Tanaka S, Horie H, Tanabe Y, Goto Y.

J Neuropathol Exp Neurol. 2007 Feb;66(2):117-23.

PMID:
17278996
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk